Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1863]
News [4262]
Articles [399]
Editorials [10]
Conferences [107]
elearning [41]
Two anti-HER2 antibodies better than one
Two anti-HER2 antibodies better than one
Advantages and motivations uncertain behind use of brachytherapy for breast cancer radiotherapy
Advantages and motivations uncertain behind use of brachytherapy for breast cancer radiotherapy
Breast cancer and heart disease may have common roots
Breast cancer and heart disease may have common roots
No brakes on breast cancer cells
No brakes on breast cancer cells
A micro-RNA regulon involved in endothelial cell recruitment and metastasis
A micro-RNA regulon involved in endothelial cell recruitment and metastasis
SABCS 2011: Zoledronic acid shows long-term benefit in survivorship for premenopausal ER-positive breast cancer
SABCS 2011: Zoledronic acid shows long-term benefit in survivorship for premenopausal ER-positive breast cancer
SABCS 2011: Clodronate appeared safe, modestly affected breast cancer disease events
SABCS 2011: Clodronate appeared safe, modestly affected breast cancer disease events
SABCS 2011: Immediate bisphosphonate use with endocrine therapy reduced recurrence, increased survival in postmenopausal early breast cancer
SABCS 2011: Immediate bisphosphonate use with endocrine therapy reduced recurrence, increased survival in...
SABCS 2011: Oral bisphosphonate did not improve prognosis for patients with breast cancer
SABCS 2011: Oral bisphosphonate did not improve prognosis for patients with breast cancer
SABCS 2011: Dual HER2 blockade significantly extends progression-free survival
SABCS 2011: Dual HER2 blockade significantly extends progression-free survival

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation